Benzinga's Top #PreMarket Losers

By: via Benzinga
KaloBios Pharmaceuticals Inc (NASDAQ: KBIO) shares dipped 53.24 percent to $11.03 in pre-market trading. Turing Pharmaceuticals ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.